Abstract

The use of SSRIs for the treatment of depression and anxiety in young people is increasing.

However, the effects of SSRIs in adolescence, a time when there are substantial changes in neural, cognitive, and social functioning, are not well understood.

Here, we review evidence from clinical trials about the benefits and risks of SSRIs in young people and consider their mechanisms of action, as shown through human experimental work and animal models.

We emphasise key outstanding questions about the effects of SSRIs in youth, identified through gaps in the literature and in consultation with young people with lived experience.

It is crucial to characterise the mechanisms underpinning risks and benefits of SSRIs in this age group to progress the field, and to narrow the chasm between the widespread use of SSRIs in youth and the science on which this use is based.

Citations

usannah E Murphy, Liliana P Capitão, Sophie L C Giles, Philip J Cowen, Argyris Stringaris, Catherine J Harmer, The knowns and unknowns of SSRI treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action, The Lancet Psychiatry, Volume 8, Issue 9, 2021, Pages 824-835

Sponsorship: Supported by the NIHR

DOI: https://doi.org/10.1016/S2215-0366(21)00154-1

URI: https://www.oxfordhealth.nhs.uk/orka/title/the-knowns-and-unknowns-of-ssri-treatment-in-young-people-with-depression-and-anxiety-efficacy-predictors-and-mechanisms-of-action/